Home › Depression › Nevada › Las Vegas
Depression clinical trials in Las Vegas, NV
6 studies for Depression are looking for participants at sites in and around Las Vegas (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
RecruitingPhase 3
- Redbird Research, LLC, Las Vegas
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
RecruitingPhase 3
- Vector Clinical Trials, Las Vegas
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
RecruitingPhase 2
- Clinical Research Site, Las Vegas
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
RecruitingPhase 2
- Draig Clinical Site, Las Vegas
Brexanolone Lifting Outcomes Of Moms
RecruitingPhase 3
- Lipocine Investigational Site, Las Vegas
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
RecruitingPhase 4
- Clinical Research Site, Las Vegas
About Depression
Depression is a serious medical illness. It affects almost 7 percent of U.S. adults. It causes feelings of sadness, hopelessness, and frustration that do not go away. Learn about treatments.
More about Depression on MedlinePlus
Depression trials in other cities
- Boston, MA50 studies
- New York City, NY44 studies
- Chicago, IL26 studies
- Atlanta, GA22 studies
- Pittsburgh, PA22 studies
- Philadelphia, PA21 studies
- Charleston, SC18 studies
- San Diego, CA18 studies
- Houston, TX18 studies
- Los Angeles, CA17 studies
- Washington, DC16 studies
- San Francisco, CA15 studies
Other studies in Las Vegas
- Obesity21 studies
- Overweight19 studies
- Type 2 Diabetes17 studies
- Major Depressive Disorder13 studies
- Breast Cancer11 studies
- Non-Small Cell Lung Cancer10 studies
- Cancer (all types)9 studies
- Metastatic Cancer8 studies
- Colorectal Cancer8 studies
- Schizophrenia7 studies
- Prostate Cancer7 studies
- Alzheimer's Disease7 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.